Although its growth rate has been cause for concern for investors in recent years, Pfizer (PFE +0.33%) is a stock that I ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pfizer is ‌reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said ​in a letter to Chancellor Friedrich ​Merz, citing the government's policy proposals ⁠that would ...

Pfizer inking the last of three settlements to postpone copycats to its transthyretin amyloid cardiomyopathy (ATTR-CM) med Vyndamax was expected to signal good news for BridgeBio and its rival therapy ...

Pfizer posted a slight revenue decline of 1.16% while absorbing a massive COVID hangover and betting billions on obesity drugs it does not yet own commercially. READ: The analyst who called NVIDIA in ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. On April 13, UBS Group AG raised its price recommendation on Pfizer Inc. (NYSE:PFE) to $27 from $25. It maintained ...

Pharmaceutical stocks are drawing renewed attention as investors look for areas of the market that can hold up in a more uncertain environment. As volatility increases and growth expectations become ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Pfizer and Valneva’s Lyme disease vaccine cut cases by about 73% in a Phase 3 trial, but missed its primary statistical ...

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were both leaders in the coronavirus vaccine market. However, as sales of these products have declined significantly in recent years -- due to the ...

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy right now. Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced on February 27 positive results from the Phase 3 EV-304 ...

Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company ...

Sanofi SA (NASDAQ: SNY) has been found to have violated the U.K.'s pharmaceutical marketing code after a senior executive made misleading claims in an October 2024 interview, prompting a complaint ...